EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Forced expiratory volume in the 6 s and forced expiratory volume in the 1 s/forced expiratory volume in the 6 s for early detection of airflow obstruction

Therese S. Ghatas, Moheb W. Elfaizy

Journal of Medicine in Scientific Research · 2023-01-01 · 6 (1)

DOI: 10.59299/2537-0928.1035 ↗
AstrattDettalji biblijografiċi

Astratt

Introduction Use of affordable and simple tools for screening chronic obstructive pulmonary disease (COPD) is limited. In recent years, measurement of forced expiratory volume in the 6 s (FEV6) has been researched as a substitute to replace forced vital capacity measurements. This work was performed to analyze the effectiveness of a simplified handheld forced expiratory flowmeter device and to search an optimal cutoff value of FEV1/FEV6 to detect airflow narrowing and limitation. Patients and methods This was a cross-section study for screening and finding of active case among undiagnosed patients with COPD using a simple handheld spirometry device, and the results were compared with the results from conventional spirometry. Result A total of 164 participants were included in this study, and only 28.6% were discovered with limitation of airflow using traditional spirometry. FEV1, FEV6, and FEV1/FEV6 were determined using a handheld expiratory flowmeter. FEV1/FEV6 showed a strong correlation with FEV1/forced vital capacity, which was detected by traditional spirometry (r=0.741, P Conclusion Measurement of FEV6 and FEV1/FEV6 by simple handheld spirometry might be useful for early detection of airflow obstruction. Patients with abnormal results, detected using a cutoff value of FEV1/FEV6 of less than 0.73, should be transferred and subjected to additional traditional spirometry evaluations for confirmation of COPD.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →